Showing results 2 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2016 | |||
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma Journal:Cancer Chemotherapy and Pharmacology | 2013 | ||
2012 | |||
Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma Journal:Future Oncology | 2011 | ||
The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines Journal:Investigational New Drugs | 2010 |